Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic–Intraosseous Administration

Duchenne muscular dystrophy (DMD) is a lethal X-linked disease caused by mutations in the dystrophin gene, leading to muscle degeneration and wasting. Electromyography (EMG) is an objective electrophysiological biomarker of muscle fiber function in muscular dystrophies. A novel, DT-DEC01 therapy, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Niezgoda, Adam, Biegański, Grzegorz, Wachowiak, Jacek, Czarnota, Jarosław, Siemionow, Krzysztof, Heydemann, Ahlke, Ziemiecka, Anna, Sikorska, Maria H., Bożyk, Katarzyna, Siemionow, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673998/
https://www.ncbi.nlm.nih.gov/pubmed/37999748
http://dx.doi.org/10.1007/s00005-023-00691-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673998/
https://www.ncbi.nlm.nih.gov/pubmed/37999748
http://dx.doi.org/10.1007/s00005-023-00691-y

Ejemplares similares